| Literature DB >> 35265799 |
Deniz Kilic1, Ismail Aydin2, Muhammed Rasit Sirem1, Hatice Birgin3, Soner Guven1.
Abstract
Objectives: To determine whether treatment time of congenital nasolacrimal duct obstruction (CNLDO) has any effect on refractive amblyopia risk factors (ARFs).Entities:
Keywords: Astigmatism; congenital nasolacrimal duct obstruction; probing; refractive errors
Year: 2022 PMID: 35265799 PMCID: PMC8874263 DOI: 10.14744/bej.2021.30974
Source DB: PubMed Journal: Beyoglu Eye J ISSN: 2459-1777
Refractive amblyopia risk factors regarding ages
| Age (months) | Refractive risk factors | |||
|---|---|---|---|---|
|
| ||||
| Myopia | Hyperopia | Anisometropia | Astigmatism | |
| <30 | > -3.5 D | > 4.5 D | > 2.5 D | > 2.0 D |
| 31-48 | > -3.0 D | > 4.0 D | > 2.0 D | > 2.0 D |
| >48 months | > -1.5 D | > 3.5 D | > 1.5 D | > 1.5 D |
D: diopters.
Clinical characteristics of children
| Early probing (n=122) | Late probing (n=52) | Total (n=174) | p | |
|---|---|---|---|---|
| Age -months | ||||
| M±Sd (range) | 15.02±3.65 (6-23) | 28.79±3.92 (24-36) | 20.17±3.22 (6-36) | <0.001[ |
| Sex (male-%) | 58–47.5% | 26 - 50% | 84-48.2% | 0.866[ |
| Laterality of NLDO | ||||
| right eyes (number-%) | 62-50.8% | 29-55.7% | 91-52.2% | 0.687[ |
| left eyes (number-%) | 50-40.1% | 20-38.5% | 70-40.2% | 0.656[ |
| Both eyes (number-%) | 10-8.2 % | 3-5.8% | 13-7.5% | 0.122[ |
| Success rate of Probing (Number- %) | 109-89.3% | 44-84.6% | 153-87.9% | 0.381[ |
NLDO; nasolacrimal duct obstruction; boldface, significant values, P < 0.05;
Independent samples t-test;
chi-square.
Refractive amblyopia risk factors according to the groups
| Early probing (n=133 eyes) | Late probing (n=56 eyes) | Total (189 eyes) | p | |
|---|---|---|---|---|
| Myopia (n-%) | 2 (1.5%) | 0 (0%) | 2 (1.1%) | 0.885 |
| Hyperopia (n-%) | 3(2.3%) | 3 (5.4%) | 6 (3.25%) | 0.364 |
| Astigmatism (n-%) | 13 (9.8%) | 12 (21.4%) | 25 (13.2%) | 0.037 |
| Anisometropia (n- %) | 5 (3.8%) | 1 (1.8%) | 6 (3.2%) | 0.672 |
| Total (n- %) | 23 (17.3%) | 17 (30.4%) | 40 (21.2%) | 0.044 |
, Chi-square test; boldface, significant values, p<0.05